Skip to main content

Table 2 Cancer Detection Rate and Gleason pattern

From: The addition of a sagittal image fusion improves the prostate cancer detection in a sensor-based MRI /ultrasound fusion guided targeted biopsy

 

Group A (n = 162)

Group B (N = 89)

p-value

Overall CDR

117 (72%)

76 (85%)

0.019

SB

108 (67%)

68 (76%)

0.115

TB

89 (55%)

68 (76%)

0.001

PI-RADS 3 (n = 39)

 Overall CDR

17 (55%)

5 (63%)

>0.999

 SB

15 (48%)

3 (38%)

0.702

 TB

13 (42%)

2 (25%)

0.450

PI-RADS 4 (n = 126)

 Overall CDR

55 (66%)

36 (84%)

0.058

 SB

48 (58%)

33 (77%)

0.049

 TB

40 (48%)

32 (74%)

0.007

PI-RADS 5 (n = 86)

 Overall CDR

45 (94%)

35 (92%)

>0.999

 SB

45 (94%)

32 (84%)

0.175

 TB

36 (75%)

34 (90%)

0.102

Detected GS ≥7 in TB

54 (61%)

53 (78%)

0.025

Missed PCa (GS ≥7) in TB

18 (33%*)

5 (9%*)

0.072

  1. CDR = Cancer Dection Rate; GS = Gleason Score; SB = Random Biopsy; TB = Target biopsy; * % of GS ≥7 detected by TB
Back to article page

BMC Urology

ISSN: 1471-2490

Contact us